187 related articles for article (PubMed ID: 12439719)
21. Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.
Planque C; Bléchet C; Ayadi-Kaddour A; Heuzé-Vourc'h N; Dumont P; Guyétant S; Diamandis EP; El Mezni F; Courty Y
Biol Chem; 2008 Jun; 389(6):781-6. PubMed ID: 18627302
[TBL] [Abstract][Full Text] [Related]
22. Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
Luo LY; Diamandis EP; Look MP; Soosaipillai AP; Foekens JA
Br J Cancer; 2002 Jun; 86(11):1790-6. PubMed ID: 12087468
[TBL] [Abstract][Full Text] [Related]
23. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.
Bièche I; Girault I; Sabourin JC; Tozlu S; Driouch K; Vidaud M; Lidereau R
Br J Cancer; 2003 Mar; 88(6):863-70. PubMed ID: 12644823
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
Jiao X; Lu HJ; Zhai MM; Tan ZJ; Zhi HN; Liu XM; Liu CH; Zhang DP
World J Gastroenterol; 2013 Dec; 19(48):9425-31. PubMed ID: 24409072
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Yousef GM; Scorilas A; Katsaros D; Fracchioli S; Iskander L; Borgono C; Rigault de la Longrais IA; Puopolo M; Massobrio M; Diamandis EP
J Clin Oncol; 2003 Aug; 21(16):3119-26. PubMed ID: 12915603
[TBL] [Abstract][Full Text] [Related]
27. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
28. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
Diamandis EP; Borgoño CA; Scorilas A; Yousef GM; Harbeck N; Dorn J; Schmalfeldt B; Schmitt M
Tumour Biol; 2003; 24(6):299-309. PubMed ID: 15004490
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
[TBL] [Abstract][Full Text] [Related]
30. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
Talieri M; Devetzi M; Scorilas A; Pappa E; Tsapralis N; Missitzis I; Ardavanis A
Tumour Biol; 2012 Aug; 33(4):1075-84. PubMed ID: 22351561
[TBL] [Abstract][Full Text] [Related]
31. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
32. Human tissue kallikreins: a family of new cancer biomarkers.
Diamandis EP; Yousef GM
Clin Chem; 2002 Aug; 48(8):1198-205. PubMed ID: 12142373
[TBL] [Abstract][Full Text] [Related]
33. Human kallikrein 10, a predictive marker for breast cancer.
Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V
Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732
[TBL] [Abstract][Full Text] [Related]
34. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
Obiezu CV; Scorilas A; Katsaros D; Massobrio M; Yousef GM; Fracchioli S; Rigault de la Longrais IA; Arisio R; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2380-6. PubMed ID: 11489816
[TBL] [Abstract][Full Text] [Related]
35. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk.
Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP
Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124
[TBL] [Abstract][Full Text] [Related]
36. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.
Overgaard J; Yilmaz M; Guldberg P; Hansen LL; Alsner J
Acta Oncol; 2000; 39(3):327-33. PubMed ID: 10987229
[TBL] [Abstract][Full Text] [Related]
37. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.
Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA
Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients.
Gong W; Liu Y; Preis S; Geng X; Petit-Courty A; Kiechle M; Muckenhuber A; Dreyer T; Dorn J; Courty Y; Magdolen V
Mol Med; 2020 Feb; 26(1):19. PubMed ID: 32028882
[TBL] [Abstract][Full Text] [Related]
39. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines.
Paliouras M; Diamandis EP
Breast Cancer Res Treat; 2007 Mar; 102(1):7-18. PubMed ID: 16897430
[TBL] [Abstract][Full Text] [Related]
40. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
Borgoño CA; Fracchioli S; Yousef GM; Rigault de la Longrais IA; Luo LY; Soosaipillai A; Puopolo M; Grass L; Scorilas A; Diamandis EP; Katsaros D
Int J Cancer; 2003 Sep; 106(4):605-610. PubMed ID: 12845660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
